Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination
Open Access
- 7 October 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature
- Vol. 600 (7889), 517-522
- https://doi.org/10.1038/s41586-021-04060-7
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection produces B cell responses that continue to evolve for at least one year. During that time, memory B cells express increasingly broad and potent antibodies that are resistant to mutations found in variants of concern1. As a result, vaccination of coronavirus disease 2019 (COVID-19) convalescent individuals with currently available mRNA vaccines produces high levels of plasma neutralizing activity against all variants tested1,2. Here we examine memory B cell evolution 5 months after vaccination with either Moderna (mRNA-1273) or Pfizer-BioNTech (BNT162b2) mRNA vaccines in a cohort of SARS-CoV-2 naive individuals. Between prime and boost, memory B cells produce antibodies that evolve increased neutralizing activity, but there is no further increase in potency or breadth thereafter. Instead, memory B cells that emerge 5 months after vaccination of naive individuals express antibodies that are similar to those that dominate the initial response. While individual memory antibodies selected over time by natural infection have greater potency and breadth than antibodies elicited by vaccination, the overall neutralizing potency of plasma is greater following vaccination. These results suggest that boosting vaccinated individuals with currently available mRNA vaccines will increase plasma neutralizing activity but may not produce antibodies with equivalent breadth to those obtained by vaccinating convalescent individuals.Keywords
This publication has 63 references indexed in Scilit:
- High frequency of shared clonotypes in human B cell receptor repertoiresNature, 2019
- Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routesJournal of Controlled Release, 2015
- Long-Lived Plasma Cells Are Contained within the CD19−CD38hiCD138+ Subset in Human Bone MarrowImmunity, 2015
- Change-O: a toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing dataBioinformatics, 2015
- Apoptosis and antigen affinity limit effector cell differentiation of a single naïve B cellScience, 2015
- Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cellsProceedings of the National Academy of Sciences of the United States of America, 2012
- Germinal CentersAnnual Review of Immunology, 2012
- Different B Cell Populations Mediate Early and Late Memory During an Endogenous Immune ResponseScience, 2011
- Rapid cloning of high-affinity human monoclonal antibodies against influenza virusNature, 2008
- Duration of Humoral Immunity to Common Viral and Vaccine AntigensThe New England Journal of Medicine, 2007